Walgreens Bts Aln Cm (WBA) 82.33 $WBA Rite Aid
Post# of 273331
Posted On: 03/26/2016 1:05:01 AM
Walgreens Bts Aln Cm (WBA) 82.33 $WBA
Rite Aid to Release Fourth Quarter Results on April 7
Business Wire - Thu Mar 24, 3:15PM CDT
Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2016 Fourth Quarter at 7 a.m. Eastern time Thursday, April 7, 2016. Given the company's pending merger with Walgreens Boots Alliance, Inc. (Nasdaq: WBA), Rite Aid will not be holding a conference call. The text of the earnings release, along with the corresponding charts and supplemental information slides, will be made available immediately after the release in the Investor Relations section of the company's website at www.riteaid.com.
WBA: 82.33 (-0.01), RAD: 8.07 (+0.07)
Conn's (CONN) to Report Q4 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 8:40AM CDT
Conn's Inc. (CONN) is slated to report its fourth-quarter fiscal 2016 results on Mar 29.
WBA: 82.33 (-0.01), CONN: 15.82 (-0.32), OLLI: 22.01 (-0.67), STZ: 149.90 (-0.21)
Walgreens Flu Index(TM) for Week of March 20, 2016
Business Wire - Thu Mar 24, 8:00AM CDT
The Walgreens Flu Index(TM) is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.
WBA: 82.33 (-0.01)
What's in Store for Pacific Sunwear (PSUN) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Mar 22, 8:00AM CDT
Anaheim, CA-based specialty retailer, Pacific Sunwear of California Inc. (PSUN), is expected to report fourth-quarter fiscal 2015 results on Mar 23.
WBA: 82.33 (-0.01), PSUN: 0.12 (unch), GME: 30.27 (-0.10), STZ: 149.90 (-0.21)
Walgreens Buys AmerisourceBergen Shares per Warrants
Zacks Equity Research - Zacks Investment Research - Mon Mar 21, 4:24PM CDT
Walgreens Boots Alliance, Inc. (WBA) announced that it has exercised warrants to purchase 22.7 million shares of AmerisourceBergen Corp. (ABC) for approximately $1.17 billion.
ABC: 86.17 (-1.10), WBA: 82.33 (-0.01), ARQL: 1.63 (+0.06), CORT: 4.29 (+0.10)
This Was the Best Performing Healthcare ETF Last Week
Brian Feroldi, The Motley Fool - Motley Fool - Sat Mar 19, 10:30PM CDT
IMAGE CREDIT: TBIT ON PIXABAY. It was a good week to have money in the markets, as the S&P 500 inched 0.80% higher during the past few trading days. The famous index has now fully recovered from its horrendous start to the year and has...
IHF: 119.69 (-0.53), WBA: 82.33 (-0.01), DVA: 71.55 (-0.77), UNH: 128.59 (-1.20)
Outsourcer Genpact Rebuilds In GE’s Shrinking Shadow
at Investor's Business Daily - Fri Mar 18, 2:38PM CDT
Genpact (G) has made its mark helping companies operate more efficiently, but over the last two years the business processing firm has invested heavily to make its own firm run more effectively. The company, once an India-based arm of General...
BMO: 58.80 (-0.72), EXLS: 49.55 (-0.05), GE: 31.11 (+0.04), MDLZ: 39.51 (-0.43), G: 26.35 (unch), HON: 111.32 (-0.89), KMB: 133.55 (-0.43), INFY: 18.81 (+0.15), BA: 132.12 (-0.74), WNS: 29.85 (+0.33), WBA: 82.33 (-0.01), WIT: 12.40 (+0.09), AZN: 28.00 (-0.01), ACN: 114.30 (+6.64), CTSH: 60.32 (+1.26)
What Investors Are Saying About Valeant Pharmaceuticals (VRX)
Andrew Steele - Zacks Investment Research - Fri Mar 18, 1:38PM CDT
Valeant Pharmaceuticals stock is down to a 52-week-low essentially. Check out what investors are saying about the matter.
VRX: 31.09 (-2.34), WBA: 82.33 (-0.01)
Walgreens spends nearly $1.2 B on AmerisourceBergen shares
By The Associated Press - AP - Fri Mar 18, 11:06AM CDT
Walgreens is spending nearly $1.2 billion to build its stake in AmerisourceBergen, the pharmaceutical wholesaler that supplies its drugstores, mail order and specialty pharmaceutical businesses.
ABC: 86.17 (-1.10), WBA: 82.33 (-0.01), RAD: 8.07 (+0.07)
Walgreens Boots Alliance Exercises Warrants to Purchase AmerisourceBergen Shares
Business Wire - Fri Mar 18, 9:13AM CDT
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has exercised warrants to purchase 22,696,912 shares of AmerisourceBergen Corporation (NYSE: ABC) common stock for an aggregate payment of approximately $1.17 billion. The transaction was funded using existing cash on hand.
ABC: 86.17 (-1.10), WBA: 82.33 (-0.01)
Valeant Pharmaceuticals (VRX) in Focus after Epic Decline
Zacks Equity Research - Zacks Investment Research - Thu Mar 17, 3:20PM CDT
Valeant Pharmaceuticals International, Inc. (VRX) found itself in troubled waters again with the release of dismal preliminary fourth-quarter results and a trimmed guidance for the first quarter and 2016.
VRX: 31.09 (-2.34), WBA: 82.33 (-0.01), SCMP: 10.20 (+0.06), CORT: 4.29 (+0.10)
The 2 Best Tech Stocks to Buy for Long-Term Investing
Maher Syed - Zacks Investment Research - Thu Mar 17, 11:25AM CDT
If you believe in the power of technology, you don't want to overlook these companies.
FDX: 162.65 (+0.02), AMZN: 582.95 (+13.32), WBA: 82.33 (-0.01), FB: 113.05 (+0.51), ATSG: 14.42 (+0.11), SNE: 25.47 (-0.10), GOOGL: 754.84 (-2.72), INTC: 31.88 (-0.12), SHLD: 15.00 (+0.04), UPS: 105.43 (+0.55)
OptumRx and Walgreens Partner to Improve Consumer Convenience, Cost Savings and Outcomes
Business Wire - Thu Mar 17, 7:00AM CDT
--Integrating OptumRx's pharmacy care services solutions with Walgreens leading drugstore services will help reduce pharmacy costs and improve health outcomes
WBA: 82.33 (-0.01), UNH: 128.59 (-1.20)
Valeant Trims View, Likely to Face Credit Default; Shares Fall
Zacks Equity Research - Zacks Investment Research - Wed Mar 16, 4:42PM CDT
Shares of Valeant Pharmaceuticals International, Inc. (VRX) plunged 51.5% after the company announced preliminary results for the fourth quarter of 2015 and slashed its outlook for 2016.
VRX: 31.09 (-2.34), WBA: 82.33 (-0.01), CORT: 4.29 (+0.10)
Walgreens and The Leukemia & Lymphoma Society Create New Approach to Support Cancer Patients in their Communities
PR Newswire - Wed Mar 16, 2:45PM CDT
The Leukemia & Lymphoma Society (LLS) and Walgreen Co. today announced the launch of an innovative collaboration designed to further advance cancer therapies and address the changing treatment model facing patients with blood and other cancers. The collaboration, between LLS and Walgreens Specialty Pharmacy, builds on the heritage of Walgreens in serving its communities, and the 66-year history of LLS, which has invested more than $1 billion in research to advance blood cancer treatments and cures.
WBA: 82.33 (-0.01)
Is Valeant a "Bad News Buy"?
Todd Campbell, The Motley Fool - Motley Fool - Wed Mar 16, 2:02PM CDT
CEO Pearson faces a host of challenges this year. Valeant Pharmaceuticals is under the gun to address a slate of difficult problems threatening it, and it's not clear when management will be able to say its struggles are truly behind it. Can...
VRX: 31.09 (-2.34), WBA: 82.33 (-0.01)
Why Walgreens Boots (WBA) Should Be in Your Portfolio Now
Zacks Equity Research - Zacks Investment Research - Wed Mar 16, 1:30PM CDT
Currently, Walgreens Boots (WBA) is focused on the proposed takeover of the U.S. retail pharmacy chain ??? Rite Aid ??? for $17.2 billion.
WBA: 82.33 (-0.01), OFIX: 40.65 (-0.27), HRC: 48.48 (-0.12), OSUR: 6.85 (+0.03)
This Dividend Aristocrat Is Cementing Its Global Conquest of the Booming Pharmacy Industry
at The Street - Wed Mar 16, 1:19PM CDT
Drug markers are taking it on the chin as political pressure mounts on high drug prices, but that's all to the benefit of the world's biggest (and growing) pharmacy chain.
VRX: 31.09 (-2.34), WBA: 82.33 (-0.01)
Walgreens Boots Alliance (WBA) Stock Initiated With 'Outperform' Rating at Credit Suisse
at The Street - Wed Mar 16, 8:43AM CDT
Walgreens Boots Alliance (WBA) stock was initiated with an 'outperform' rating at Credit Suisse, which said the firm is still skeptical of the company's long-term growth prospects.
WBA: 82.33 (-0.01)
Rite Aid to Release Fourth Quarter Results on April 7
Business Wire - Thu Mar 24, 3:15PM CDT
Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2016 Fourth Quarter at 7 a.m. Eastern time Thursday, April 7, 2016. Given the company's pending merger with Walgreens Boots Alliance, Inc. (Nasdaq: WBA), Rite Aid will not be holding a conference call. The text of the earnings release, along with the corresponding charts and supplemental information slides, will be made available immediately after the release in the Investor Relations section of the company's website at www.riteaid.com.
WBA: 82.33 (-0.01), RAD: 8.07 (+0.07)
Conn's (CONN) to Report Q4 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 8:40AM CDT
Conn's Inc. (CONN) is slated to report its fourth-quarter fiscal 2016 results on Mar 29.
WBA: 82.33 (-0.01), CONN: 15.82 (-0.32), OLLI: 22.01 (-0.67), STZ: 149.90 (-0.21)
Walgreens Flu Index(TM) for Week of March 20, 2016
Business Wire - Thu Mar 24, 8:00AM CDT
The Walgreens Flu Index(TM) is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.
WBA: 82.33 (-0.01)
What's in Store for Pacific Sunwear (PSUN) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Mar 22, 8:00AM CDT
Anaheim, CA-based specialty retailer, Pacific Sunwear of California Inc. (PSUN), is expected to report fourth-quarter fiscal 2015 results on Mar 23.
WBA: 82.33 (-0.01), PSUN: 0.12 (unch), GME: 30.27 (-0.10), STZ: 149.90 (-0.21)
Walgreens Buys AmerisourceBergen Shares per Warrants
Zacks Equity Research - Zacks Investment Research - Mon Mar 21, 4:24PM CDT
Walgreens Boots Alliance, Inc. (WBA) announced that it has exercised warrants to purchase 22.7 million shares of AmerisourceBergen Corp. (ABC) for approximately $1.17 billion.
ABC: 86.17 (-1.10), WBA: 82.33 (-0.01), ARQL: 1.63 (+0.06), CORT: 4.29 (+0.10)
This Was the Best Performing Healthcare ETF Last Week
Brian Feroldi, The Motley Fool - Motley Fool - Sat Mar 19, 10:30PM CDT
IMAGE CREDIT: TBIT ON PIXABAY. It was a good week to have money in the markets, as the S&P 500 inched 0.80% higher during the past few trading days. The famous index has now fully recovered from its horrendous start to the year and has...
IHF: 119.69 (-0.53), WBA: 82.33 (-0.01), DVA: 71.55 (-0.77), UNH: 128.59 (-1.20)
Outsourcer Genpact Rebuilds In GE’s Shrinking Shadow
at Investor's Business Daily - Fri Mar 18, 2:38PM CDT
Genpact (G) has made its mark helping companies operate more efficiently, but over the last two years the business processing firm has invested heavily to make its own firm run more effectively. The company, once an India-based arm of General...
BMO: 58.80 (-0.72), EXLS: 49.55 (-0.05), GE: 31.11 (+0.04), MDLZ: 39.51 (-0.43), G: 26.35 (unch), HON: 111.32 (-0.89), KMB: 133.55 (-0.43), INFY: 18.81 (+0.15), BA: 132.12 (-0.74), WNS: 29.85 (+0.33), WBA: 82.33 (-0.01), WIT: 12.40 (+0.09), AZN: 28.00 (-0.01), ACN: 114.30 (+6.64), CTSH: 60.32 (+1.26)
What Investors Are Saying About Valeant Pharmaceuticals (VRX)
Andrew Steele - Zacks Investment Research - Fri Mar 18, 1:38PM CDT
Valeant Pharmaceuticals stock is down to a 52-week-low essentially. Check out what investors are saying about the matter.
VRX: 31.09 (-2.34), WBA: 82.33 (-0.01)
Walgreens spends nearly $1.2 B on AmerisourceBergen shares
By The Associated Press - AP - Fri Mar 18, 11:06AM CDT
Walgreens is spending nearly $1.2 billion to build its stake in AmerisourceBergen, the pharmaceutical wholesaler that supplies its drugstores, mail order and specialty pharmaceutical businesses.
ABC: 86.17 (-1.10), WBA: 82.33 (-0.01), RAD: 8.07 (+0.07)
Walgreens Boots Alliance Exercises Warrants to Purchase AmerisourceBergen Shares
Business Wire - Fri Mar 18, 9:13AM CDT
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has exercised warrants to purchase 22,696,912 shares of AmerisourceBergen Corporation (NYSE: ABC) common stock for an aggregate payment of approximately $1.17 billion. The transaction was funded using existing cash on hand.
ABC: 86.17 (-1.10), WBA: 82.33 (-0.01)
Valeant Pharmaceuticals (VRX) in Focus after Epic Decline
Zacks Equity Research - Zacks Investment Research - Thu Mar 17, 3:20PM CDT
Valeant Pharmaceuticals International, Inc. (VRX) found itself in troubled waters again with the release of dismal preliminary fourth-quarter results and a trimmed guidance for the first quarter and 2016.
VRX: 31.09 (-2.34), WBA: 82.33 (-0.01), SCMP: 10.20 (+0.06), CORT: 4.29 (+0.10)
The 2 Best Tech Stocks to Buy for Long-Term Investing
Maher Syed - Zacks Investment Research - Thu Mar 17, 11:25AM CDT
If you believe in the power of technology, you don't want to overlook these companies.
FDX: 162.65 (+0.02), AMZN: 582.95 (+13.32), WBA: 82.33 (-0.01), FB: 113.05 (+0.51), ATSG: 14.42 (+0.11), SNE: 25.47 (-0.10), GOOGL: 754.84 (-2.72), INTC: 31.88 (-0.12), SHLD: 15.00 (+0.04), UPS: 105.43 (+0.55)
OptumRx and Walgreens Partner to Improve Consumer Convenience, Cost Savings and Outcomes
Business Wire - Thu Mar 17, 7:00AM CDT
--Integrating OptumRx's pharmacy care services solutions with Walgreens leading drugstore services will help reduce pharmacy costs and improve health outcomes
WBA: 82.33 (-0.01), UNH: 128.59 (-1.20)
Valeant Trims View, Likely to Face Credit Default; Shares Fall
Zacks Equity Research - Zacks Investment Research - Wed Mar 16, 4:42PM CDT
Shares of Valeant Pharmaceuticals International, Inc. (VRX) plunged 51.5% after the company announced preliminary results for the fourth quarter of 2015 and slashed its outlook for 2016.
VRX: 31.09 (-2.34), WBA: 82.33 (-0.01), CORT: 4.29 (+0.10)
Walgreens and The Leukemia & Lymphoma Society Create New Approach to Support Cancer Patients in their Communities
PR Newswire - Wed Mar 16, 2:45PM CDT
The Leukemia & Lymphoma Society (LLS) and Walgreen Co. today announced the launch of an innovative collaboration designed to further advance cancer therapies and address the changing treatment model facing patients with blood and other cancers. The collaboration, between LLS and Walgreens Specialty Pharmacy, builds on the heritage of Walgreens in serving its communities, and the 66-year history of LLS, which has invested more than $1 billion in research to advance blood cancer treatments and cures.
WBA: 82.33 (-0.01)
Is Valeant a "Bad News Buy"?
Todd Campbell, The Motley Fool - Motley Fool - Wed Mar 16, 2:02PM CDT
CEO Pearson faces a host of challenges this year. Valeant Pharmaceuticals is under the gun to address a slate of difficult problems threatening it, and it's not clear when management will be able to say its struggles are truly behind it. Can...
VRX: 31.09 (-2.34), WBA: 82.33 (-0.01)
Why Walgreens Boots (WBA) Should Be in Your Portfolio Now
Zacks Equity Research - Zacks Investment Research - Wed Mar 16, 1:30PM CDT
Currently, Walgreens Boots (WBA) is focused on the proposed takeover of the U.S. retail pharmacy chain ??? Rite Aid ??? for $17.2 billion.
WBA: 82.33 (-0.01), OFIX: 40.65 (-0.27), HRC: 48.48 (-0.12), OSUR: 6.85 (+0.03)
This Dividend Aristocrat Is Cementing Its Global Conquest of the Booming Pharmacy Industry
at The Street - Wed Mar 16, 1:19PM CDT
Drug markers are taking it on the chin as political pressure mounts on high drug prices, but that's all to the benefit of the world's biggest (and growing) pharmacy chain.
VRX: 31.09 (-2.34), WBA: 82.33 (-0.01)
Walgreens Boots Alliance (WBA) Stock Initiated With 'Outperform' Rating at Credit Suisse
at The Street - Wed Mar 16, 8:43AM CDT
Walgreens Boots Alliance (WBA) stock was initiated with an 'outperform' rating at Credit Suisse, which said the firm is still skeptical of the company's long-term growth prospects.
WBA: 82.33 (-0.01)
(0)
(0)